Effects of intrastriatal cannabinoids on rotational behavior in rats: Interactions with the dopaminergic system

Synapse

Volumn 30, Issue 2, 1998, Pages 221-226

  Sañudo Peña, M Clara ^a   Force, Michelle ^a   Tsou, Kang ^a   Miller, Adrienne S ^a   Walker, J Michael ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Basal ganglia; Cannabinoids; Circling; Dopamine; Striatum

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; DOPAMINE 1 RECEPTOR; QUINPIROLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG RECEPTOR BINDING; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; ROTATION;

EID: 0031843557     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199810)30:2<221::AID-SYN12>3.3.CO;2-O     Document Type: Article

References (58)

1. 2 agonist in rats with unilateral lesions of the nigrostriatal pathway. Brain Res., 691:106-114.
2. Arnt, J., Hyttel, J., and Sanchez, C. (1992) Partial and full dopamine D1 receptor agonists in mice and rats: Relation between behavioral effects and stimulation of adenylate cyclase activity in vitro. Eur. J. Pharmacol., 213:259-267.
3. Cooper, A.J., Moser, B., and Mitchell, I.J. (1995) A subset of striatopallidal neurons are Fos-immunopositive following acute monoamine depletion in the rat. Neurosci. Lett., 187:189-192.
4. Costall, B., Naylor, R.J., and Olley, J.E. (1972) Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacology, 11:645-663.
5. Costall, B., Kelly, D.M., and Naylor, R.J. (1975) Nomifensine: A potent dopaminergic agonist of antiparkinson potential. Psychopharmacologia, 41:153-164.
6. Deadwyler, S.A., Hampson, R.E., Bennett, B.A., Edwards, T.A., Mu, J., Pacheco, M.A., Ward, S.J., and Childers, S.R. (1993) Cannabinoids modulate potassium current in culture hippocampal neurons. Receptors Channels, 1:121-134.
7. Dewey, W.L. (1986) Cannabinoid pharmacology. Pharmacol. Rev., 38:151-178.
8. Gerfen, C.R. (1995) Dopamine receptor function in the basal ganglia. Clin. Neuropharmacol., 18:S162-8177.
9. Gerfen, C.R., and Young, W.S. (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: An in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res., 460:161-167.
10. Gerfen, C.R., Engber, T.M., Mahan, L.C. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 250:1429-32.
11. Gerfen, C.R. McGinty, J.F., and Young, W.S. (1991) Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis. J. Neurosci., 11:1016-31.
12. Glass, M., and Felder, C.C. (1996) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors result in an augmentation of forskolin stimulated cAMP accumulation in striatal neurons. Soc. Neurosci. Abstr., 22:1563.
13. Gnanalingham, K.K., Hunter, A.J., Jenner, P., and Marsden, C.D. (1995) Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat-relationship to circling behavior. Biochem. Pharmacol., 49:1185-1193.
14. 9-THC in the rat. Neuropharmacology, 17:137-144.
15. Graybiel, A.M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci., 13:244-253.
16. Herkenham, M., Lynn, A.B., de Costa, B.R., and Richfield, E.K. (1991a) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res., 547:267-274.
17. Herkenham, M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., and Rice, K.C. (1991b) Characterization and localization of cannabinoid receptor in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci., 11:563-583.
18. Herrera-Marschitz, M., and Ungerstedt, U. (1987) The dopamine-γ aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: Evidence obtained with rotational behavioural experiments. Acta Physiol. Scand., 129:371-380.
19. Herrera-Marschitz, M., Forster, C., and Ungerstedt, U. (1985a) Rotational behavior elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I. Comparison between systemic and intrastriatal injections. Acta Physiol. Scand., 125:519-527.
20. Herrera-Marschitz, M., Forster, C., and Ungerstedt, U. (1985b) Rotational behavior elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. II. The striatum of the rat is heterogeneously organized for rotational behavior. Acta Physiol. Scand., 125:529-535.
21. Hollister, L.E. (1986) Health aspects of cannabis. Pharmacol. Rev., 38:1-20.
22. Howlett, A.C. (1995) Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol., 35:607-634.
23. Kawaguchi, Y., Wilson, C.J., Emson, P.C. (1990) Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci, 10:3421-3438.
24. Kawaguchi, Y, Wilson, C.J., Augood, S.J., and Emson, P.C. (1995) Striatal interneurones: Chemical, physiological and morphological characterization. Trends Neurosci., 18:527-535.
25. Keefe, K.A., and Gerfen, C.R. (1995) D1-D2 dopamine receptor synergy in striatum: Effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience, 66:903-913.
26. LeMoine, C., and Bloch, B. (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol., 35:418-426.
27. LeMoine, C., Norman, E., and Bloch, B. (1991) Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. Natl. Acad. Sci. USA, 88:4205-4209.
28. Mackie, K., and Hille, B. (1992) Cannabinoid inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA, 89:3825-3829.
29. Mackie, K., Lai, Y, Westenbroek, R., and Mitchell, R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci., 15:6552-6561.
30. Mailleux, P., and Vanderhaeghen, J.J. (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience, 48:655-688.
31. Mailleux, P., and Vanderhaeghen, J.J. (1993) Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: An in situ hybridization study. J. Neurochem., 61:1705-1712.
32. Miller, A., and Walker, J.M. (1995) Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. Eur. J. Pharmacol., 279:179-185.
33. Miller, A., and Walker, J.M. (1996) Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus. Eur. J. Pharmacol., 304:29-35.
34. Miller, A.S., Sañudo-Peña M.C., Walker, J.M. (1998) Ipsilateral turning behavior induced by unilateral microinjections of a cannabinoid into the rat subthalamic nucleus. Brain Res., 793:7-11.
35. Navarro, M., Fernandez-Ruiz, J.J., De Miguel, R., Hernandez, M.L., Cebeira, M., and Ramos, J.A. (1993) Motor disturbances induced by an acute dose of δ9-tetrahydrocannabinol: Possible involvement of nigrostriatal dopaminergic alterations. Pharmacol. Biochem. Behav., 45:291-298.
36. Nissenbaum, L.K., Kitai, S.T., and Gerfen, C.R. (1994) Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: Effects of systemic and central administration of quinpirole and scopolamine. Neuroscience, 63:435-449.
37. Pertwee, R.G., and Wickens, A.P. (1991) Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology, 30: 237-244.
38. Robertson, H.A., Peterson, M.R., Murphy, K., and Robertson, G.S. (1989) D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res., 503:346-349.
39. Robertson, G.S., Vincent, S.R., and Fibiger, H.C. (1990) Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Res., 523:288-290.
40. Romero, J., de Miguel, R., García-Palomero, E., Fernández-Ruiz, J.J., and Ramos, J.A. (1995) Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. Brain Res., 694:223-232.
41. B receptors in the motor inhibition produced by agonists of brain cannabinoid receptors. Behav. Pharmacol., 7:299-302.
42. 1 receptor ligand. Life Sci., 15:1249-1257.
43. 9-Tetrahydrocannabinol elicited ipsilateral circling behavior in rats with unilateral nigral lesion. Life Sci., 37:2181-2185.
44. Sañudo-Peña, M.C., and Walker, J.M. (1997) Role of the subthalamic nucleus on cannabinoid actions in the substantia nigra of the rat. J. Neurophysiol., 77:1635-1638.
45. Sanudo-Pena, M.C., and Walker, J.M. (1998a) Effects of intrapallidal cannabinoids on rotational behavior in rats: Interactions with the dopaminergic system. Synapse, 28:27-32.
46. Sañudo-Peña, M.C., Patrick, S.L., Patrick, R.L., and Walker, J.M. (1996) Effects of intranigral cannabinoids on rotational behavior in rats: Interactions with the dopaminergic system, Neurosci. Lett., 206:21-24.
47. Sañudo-Peña, M.C., Patrick, S.L., Khen, S., Patrick, R.L., Tsou, K., and Walker, J.M. (1998b) Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease. Neurosci. Lett., (in press).
48. Schweitzer, P., Madamba, S.G., Siggins, G.R., and Piomelli, D. (1996) Anandamide, the endogenous cannabinoid receptor agonist is released in rat hippocampus and decreases the potassium M-current. Soc. Neurosci. Abstr., 22:351.
49. Souilhac, J., Poncelet, M., Rinaldi-Carmona, M., Le-Fur, G., and Soubrie, P. (1995) Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacol. Biochem. Behav., 51:3-7.
50. Stark, P., and Dews, P.B. (1980) Cannabinoids. I. Behavioral effects. J. Pharmacol. Exp. Ther., 214:124-130.
51. 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur. J. Pharmacol., 280:R13-R15.
52. Tsou, K., Brown, S., Sañudo-Peña, M.C., Mackie, K., and Walker, J.M. (1998) Immunohistochemicaldistribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83:393-411.
53. Wang, J.Q., and McGinty, J.F. (1996) Scopolamine augments c-fos and zif/268 messenger RNA expression induced by the full D1 dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience, 72:601-616.
54. Wickens, A.P., and Pertwee, R.G. (1993) delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. Eur. J. Pharmacol., 250:205-208.
55. 9-tetrahydrocannabinol on circling in rats induced by intranigral muscimol administration. Eur. J. Pharmacol., 282:251-254.
56. Worms, P., Gueudet, C., and Biziere, K. (1986) Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: Pharmacological analysis of a simple screening model. Life Sci., 39:2199-2208.
57. Worms, P., Chambrom, J.P., and Biziere, K. (1987) Behavioral evidence for a selective GABAA antagonistic activity of SR 95103 and SR 42641 after intrastriatal injection in mice. Eur. J. Pharmacol., 138:343-350.
58. 2 receptor agonists. Neuroscience, 63:427-434.